Knee Surgeries and Arthroplasty Pain Management Therapeutics Market
- 2026 年市場規模
- USD 4,876.4 Mn
- 2033 年預估規模
- USD 7,107.3 Mn
- 年複合成長率 CAGR
- 5.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Drug(Acetaminophen, COX-2 inhibitors, Opioids, Non-steroidal Anti-inflammatories, Ketamine, and Others ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Many types of medicines are available to help control pain, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), Acetaminophen, etc. Medications help people feel more comfortable, allowing one to start moving sooner, get the strength back more quickly, and recover from knee surgeries and arthroplasty faster.
Furthermore, increasing number of total knee arthroplasty is expected to drive the market growth over the forecast period
For instance, according to data published by National Center for Biotechnology Information in 2017, the number of total knee arthroplasty is estimated to range between 60,000 and 70,000 per year in Brazil.
Market Dynamics
Increasing research and development activities by the key players for the development and launch of knee surgeries and arthroplasty pain management drugs are expected to drive the growth of the global knee surgeries and arthroplasty pain management therapeutics market over the forecast period.
For instance, in May 2021, Allay Therapeutics, a clinical-stage biotechnology company, pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced the first-ever clinical data showing non-opioid pain relief lasting two weeks after a single administration. The existing post-surgical pain products have shown effectiveness for a maximum of three days after a single dose. The data come from a Phase 1b/2a clinical study of Allay’s first candidate, ATX-101, in development to treat pain after total knee arthroplasty (replacement) or TKA surgery.
Moreover, increasing approval of drug is also expected to boost the market growth. For instance, in march 2020, GlaxoSmithKline Plc. announced that the U.S. Food and Drug Administration had approved Advil Dual Action with Acetaminophen, as an (OTC) over-the-counter product for pain relief. Advil Dual Action gives relief for various symptoms and is the major formulation that merges acetaminophen and ibuprofen, 2 strong ingredients indicated for over-the-counter pain relief that work in different ways.
Key features of the study
• This report provides an in-depth analysis of the global knee surgeries and arthroplasty pain management therapeutics market, market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global knee surgeries and arthroplasty pain management therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc, Allay Therapeutics, Mallinckrodt, Johnson & Johnson, Zydus Cadila Healthcare Ltd., Novartis AG, Purdue Pharma, Delphis Pharmaceutical, Taj Pharmaceuticals Limited, GlaxoSmithKline plc, AbbVie Inc., and Aurobindo Pharma
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global knee surgeries and arthroplasty pain management therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global knee surgeries and arthroplasty pain management therapeutics market
Market Segmentation
• By Drug
o Acetaminophen
o COX-2 inhibitors
o Opioids
o Non-steroidal Anti-inflammatories
o Ketamine
o Others
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Regional Insights
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Pfizer Inc
o Allay Therapeutics
o Mallinckrodt
o Johnson & Johnson
o Zydus Cadila Healthcare Ltd.
o Novartis AG
o Purdue Pharma
o Delphis Pharmaceutical
o Taj Pharmaceuticals Limited
o GlaxoSmithKline plc
o AbbVie Inc.
o Aurobindo Pharma
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Drivers
o Restraints
o Opportunity
o Impact Analysis
o Number of Total Knee Arthroplasty Surgeries
o Key Developments
o Regulatory Scenario
o PEST Analysis
o Pipeline Analysis
o Overview of Postoperative Pain Management Regimes for Total Knee Arthroplasty
4. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Drug, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Acetaminophen
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o COX-2 inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Opioids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Non-steroidal Anti-inflammatories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Ketamine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Distribution Channel, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021-2033
o North America
Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
Market Size and Forecast, By Region/Country, 2021-2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
7. Competitive Landscape
o Competitive Snapshot
Pfizer Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Allay Therapeutics
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Mallinckrodt
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Johnson & Johnson
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Zydus Cadila Healthcare Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novartis AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Purdue Pharma
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Delphis Pharmaceutical
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Taj Pharmaceuticals Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
GlaxoSmithKline plc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
AbbVie Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Aurobindo Pharma
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
8. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們